| {"0": "Electron transport chain oxphos system in mitochondria", "1": "Cholesterol metabolism with bloch and kandutschrussell pathways", "2": "Cholesterol biosynthesis with skeletal dysplasias", "3": "Glycerophospholipid biosynthetic pathway", "4": "Sphingolipid metabolism overview", "5": "Sphingolipid metabolism integrated pathway", "6": "Ferroptosis", "7": "Nonalcoholic fatty liver disease", "8": "Glycerolipids and glycerophospholipids", "9": "Glycosylation and related congenital defects", "10": "Cholesterol biosynthesis pathway", "11": "Sphingolipid metabolism in senescence", "12": "Degradation pathway of sphingolipids including diseases", "13": "Oxidative phosphorylation", "14": "Glycosaminoglycan degradation", "15": "Sphingolipid pathway", "16": "Mitochondrial complex i assembly model oxphos system", "17": "Mitochondrial immune response to sarscov2", "18": "Vitamin d receptor pathway", "19": "Thermogenesis", "20": "Metapathway biotransformation phase i and ii", "21": "Type i collagen synthesis in the context of osteogenesis imperfecta", "22": "G1 to s cell cycle control", "23": "Sterol regulatory elementbinding proteins srebp signaling", "24": "Proximal tubule transport", "25": "Ppar signaling pathway", "26": "Alzheimers disease and mirna effects", "27": "Nuclear receptors metapathway", "28": "Gastric cancer network 2", "29": "Intracellular trafficking proteins involved in cmt neuropathy", "30": "Alzheimers disease", "31": "Mechanoregulation and pathology of yaptaz via hippo and nonhippo mechanisms", "32": "Angiopoietinlike protein 8 regulatory pathway", "33": "Disruption of postsynaptic signaling by cnv"} |